help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 9, 2006
Endocrinology, doi:10.1210/en.2006-1002
A more recent version of this article appeared on February 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/2/824    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowles, C. E.
Right arrow Articles by Ross, R. J.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowles, C. E.
Right arrow Articles by Ross, R. J.M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYSTEINE

Submitted on August 2, 2006
Accepted on October 27, 2006

MEMBRANE RE-INSERTION OF A MYRISTOYL-PEPTIDYL ANCHORED EXTRACELLULAR DOMAIN GROWTH HORMONE RECEPTOR

C. E. Bowles, I. Wilkinson, R. A.G. Smith, A. J.G. Moir, H. Montgomery, and R. J.M. Ross*

Section of Endocrinology and Reproduction, The University of Sheffield, UK

* To whom correspondence should be addressed. E-mail: r.j.ross{at}sheffield.ac.uk.

The actions of growth hormone (GH) are mediated through a cell surface cytokine receptor. We have previously demonstrated that naturally occurring truncated membrane bound GH receptors (GHRs) can block GH receptor signaling. We have now investigated whether recombinant extracellular GHR can be conjugated to a myristoylated-peptide (mp) tail and inserted into cell membranes to modulate GHR signaling. Recombinant human extracellular domain (1-241) GHR was expressed in Escherichia coli, purified and refolded from cell lysate. The free C-terminal cysteine was then reduced and conjugated to an activated preformed mp tail. The properties of the purified tailed GHR (GHR-mp) were then compared with those of the un-tailed purified GHR1-241. FACS analysis and cell surface binding assays demonstrated that GHR-mp inserted into the cell surface membranes of CHO cells whereas un-tailed GHR1-241 showed no insertion. In a cell based bioassay GHR-mp partially inhibited wild-type GHR signaling whereas GHR1-241 had no effect. Truncated extracellular domain GHR can, when specifically modified with a membrane-localizing mp unit, insert into cell surface membranes and modulate GHR signaling.


Key words: Growth hormone • Growth hormone receptor • Myristoylation • GH antagonist







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society